speb/financial-data huggingface dataset:
CRI cash_flow (quarterly, 2025-06-30) — Deferred Tax: -3023000.00
CRI cash_flow (quarterly, 2025-06-30) — Depreciation: 12627000.00
CRI cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 13559000.00
CRI cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 13559000.00
CRI income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 35409988.00
CRI income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.01
CRI income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 215000.00
CRI income_statement (quarterly, 2025-06-30) — EBIT: 9560000.00
CRI income_statement (quarterly, 2025-06-30) — EBITDA: 23119000.00
CRI cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 2509000.00
CRI cash_flow (quarterly, 2025-06-30) — End Cash Position: 338183000.00
CRI cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -9226000.00
CRI balance_sheet (quarterly, 2025-06-30) — Finished Goods: 619074000.00
CRI cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 24106000.00
CRI balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -32817000.00
CRI balance_sheet (quarterly, 2025-06-30) — Goodwill: 209016000.00
CRI balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 499647000.00
CRI balance_sheet (quarterly, 2025-06-30) — Gross PPE: 1358055000.00
CRI income_statement (quarterly, 2025-06-30) — Gross Profit: 281760000.00
CRI balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 4759000.00
CRI income_statement (quarterly, 2025-06-30) — Interest Expense: 7857000.00
CRI income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 7857000.00
CRI income_statement (quarterly, 2025-06-30) — Interest Income: 4292000.00
CRI income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 4292000.00
CRI balance_sheet (quarterly, 2025-06-30) — Inventory: 619074000.00
CRI balance_sheet (quarterly, 2025-06-30) — Invested Capital: 1352433000.00
CRI cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -16200000.00
CRI balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 501804000.00
CRI balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 498531000.00
CRI balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 1000335000.00
CRI cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
CRI balance_sheet (quarterly, 2025-06-30) — Net Debt: 160348000.00
CRI cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: -504000.00
CRI income_statement (quarterly, 2025-06-30) — Net Income: 446000.00
CRI income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 215000.00
CRI income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 446000.00
CRI income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 446000.00
CRI income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 446000.00
CRI cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 446000.00
CRI income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 446000.00
CRI income_statement (quarterly, 2025-06-30) — Net Interest Income: -3565000.00
CRI income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -3565000.00
CRI cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -110000.00
CRI balance_sheet (quarterly, 2025-06-30) — Net PPE: 759480000.00
CRI balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 354255000.00
CRI balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 42290000.00
CRI balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 42290000.00
CRI income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 23119000.00
CRI income_statement (quarterly, 2025-06-30) — Normalized Income: 446000.00
CRI cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 40306000.00
CRI cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -508000.00
CRI income_statement (quarterly, 2025-06-30) — Operating Income: 4044000.00
CRI income_statement (quarterly, 2025-06-30) — Operating Revenue: 585313000.00
CRI balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 36467071.00
CRI balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 60612000.00
CRI balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 25077000.00
CRI balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -32817000.00
CRI income_statement (quarterly, 2025-06-30) — Other Income Expense: 1224000.00
CRI balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 290631000.00
CRI cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 417000.00
CRI balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 38204000.00
CRI balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 33354000.00
CRI income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 1224000.00
CRI income_statement (quarterly, 2025-06-30) — Other Operating Expenses: -3249000.00
CRI balance_sheet (quarterly, 2025-06-30) — Other Properties: 1358055000.00
CRI balance_sheet (quarterly, 2025-06-30) — Other Receivables: 11281000.00
CRI income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 231000.00
CRI balance_sheet (quarterly, 2025-06-30) — Payables: 316696000.00
CRI balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 329029000.00
CRI balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 22565000.00
CRI balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
CRI income_statement (quarterly, 2025-06-30) — Pretax Income: 1703000.00
CRI cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 0.00
CRI cash_flow (quarterly, 2025-06-30) — Provisionand Write Offof Assets: 2104000.00
CRI balance_sheet (quarterly, 2025-06-30) — Receivables: 140352000.00
CRI balance_sheet (quarterly, 2025-06-30) — Receivables Adjustments Allowances: -9093000.00
CRI income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 303553000.00
CRI income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 13559000.00
CRI cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: 0.00
CRI balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 871894000.00
CRI income_statement (quarterly, 2025-06-30) — Selling General And Administration: 280965000.00
CRI balance_sheet (quarterly, 2025-06-30) — Share Issued: 36441222.00
CRI cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 5188000.00
CRI balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 853902000.00
CRI balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 354255000.00
CRI income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CRI income_statement (quarterly, 2025-06-30) — Tax Provision: 1257000.00
CRI income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
CRI balance_sheet (quarterly, 2025-06-30) — Total Assets: 2455552000.00
CRI balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 1352433000.00
CRI balance_sheet (quarterly, 2025-06-30) — Total Debt: 1124337000.00
CRI balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 853902000.00
CRI income_statement (quarterly, 2025-06-30) — Total Expenses: 581269000.00
CRI balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 1601650000.00
CRI balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 1297331000.00
CRI balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 1075979000.00
CRI income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 4044000.00
CRI balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 10297000.00
CRI cash_flow (quarterly, 2025-06-30) — Unrealized Gain Loss On Investment Securities: -145000.00
CRI balance_sheet (quarterly, 2025-06-30) — Working Capital: 632550000.00
CRI income_statement (quarterly, 2025-09-30) — +Operating Expense: 312535000.00
CRI income_statement (quarterly, 2025-09-30) — +Total Revenue: 757836000.00
CRI balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 240235000.00
CRI balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 239417000.00
CRI balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -599467000.00
CRI balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 18029000.00
CRI cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 935000.00
CRI cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 935000.00
CRI income_statement (quarterly, 2025-09-30) — Basic Average Shares: 35443712.00
CRI income_statement (quarterly, 2025-09-30) — Basic EPS: 0.32
CRI cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 338183000.00
CRI cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -16116000.00
CRI cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -16116000.00
CRI balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 679687000.00
CRI balance_sheet (quarterly, 2025-09-30) — Capital Stock: 365000.00
CRI balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 184190000.00
CRI balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 184190000.00
CRI cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -9132000.00
CRI cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -9289000.00
CRI cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -16116000.00
CRI cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -127972000.00
CRI cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -32894000.00
CRI cash_flow (quarterly, 2025-09-30) — Change In Inventory: -39607000.00
CRI cash_flow (quarterly, 2025-09-30) — Change In Payable: -32894000.00
CRI cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -32894000.00
CRI cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 4709000.00
CRI cash_flow (quarterly, 2025-09-30) — Change In Receivables: -102961000.00
CRI cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -170753000.00
CRI cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -102961000.00
CRI cash_flow (quarterly, 2025-09-30) — Changes In Cash: -153377000.00
CRI balance_sheet (quarterly, 2025-09-30) — Common Stock: 365000.00
CRI cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -9132000.00
CRI balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 864642000.00
CRI cash_flow (quarterly, 2025-09-30) — Common Stock Payments: 0.00
CRI income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 416208000.00
CRI balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 6203000.00
CRI balance_sheet (quarterly, 2025-09-30) — Current Assets: 1133781000.00
CRI balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 150548000.00
CRI balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 150548000.00
CRI balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 25318000.00
CRI balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 25318000.00
CRI balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 501690000.00
CRI cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: -2670000.00
CRI cash_flow (quarterly, 2025-09-30) — Deferred Tax: -2670000.00
CRI cash_flow (quarterly, 2025-09-30) — Depreciation: 12830000.00
CRI cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 13765000.00
CRI cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 13765000.00
CRI income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 35443858.00
CRI income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.32
CRI income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 11288000.00
CRI income_statement (quarterly, 2025-09-30) — EBIT: 22007000.00
CRI income_statement (quarterly, 2025-09-30) — EBITDA: 35772000.00
CRI cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -616000.00
CRI cash_flow (quarterly, 2025-09-30) — End Cash Position: 184190000.00
CRI cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -9289000.00
CRI balance_sheet (quarterly, 2025-09-30) — Finished Goods: 656149000.00
CRI cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -144088000.00
CRI balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -28107000.00
CRI balance_sheet (quarterly, 2025-09-30) — Goodwill: 208351000.00
CRI balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 498062000.00
CRI balance_sheet (quarterly, 2025-09-30) — Gross PPE: 1400048000.00
CRI income_statement (quarterly, 2025-09-30) — Gross Profit: 341628000.00
CRI balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 7286000.00
CRI income_statement (quarterly, 2025-09-30) — Interest Expense: 7173000.00
CRI income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 7173000.00
CRI income_statement (quarterly, 2025-09-30) — Interest Income: 2573000.00
CRI income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 2573000.00
CRI balance_sheet (quarterly, 2025-09-30) — Inventory: 656149000.00
CRI balance_sheet (quarterly, 2025-09-30) — Invested Capital: 1363380000.00
CRI cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -16116000.00
CRI balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 529139000.00
CRI balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 498738000.00
CRI balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 1027877000.00
CRI cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
CRI balance_sheet (quarterly, 2025-09-30) — Net Debt: 314548000.00
CRI cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: 406000.00
CRI income_statement (quarterly, 2025-09-30) — Net Income: 11593000.00
CRI income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 11288000.00
CRI income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 11593000.00
CRI income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 11593000.00
CRI income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 11593000.00
CRI cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 11593000.00
CRI income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 11593000.00
CRI income_statement (quarterly, 2025-09-30) — Net Interest Income: -4600000.00
CRI income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -4600000.00
CRI cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -157000.00
CRI balance_sheet (quarterly, 2025-09-30) — Net PPE: 800581000.00
CRI balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 366580000.00
CRI balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 41200000.00
CRI balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 41200000.00
CRI income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 35772000.00
CRI income_statement (quarterly, 2025-09-30) — Normalized Income: 11593000.00
CRI cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -127972000.00
CRI cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 9187000.00
CRI income_statement (quarterly, 2025-09-30) — Operating Income: 29093000.00
CRI income_statement (quarterly, 2025-09-30) — Operating Revenue: 757836000.00
CRI balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 36518637.00
CRI balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 55576000.00
CRI balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 30398000.00
CRI balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -28107000.00
CRI income_statement (quarterly, 2025-09-30) — Other Income Expense: -9659000.00
CRI balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 289711000.00
CRI cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 421000.00
CRI balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 37015000.00
CRI balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 34030000.00
CRI income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -9659000.00
CRI income_statement (quarterly, 2025-09-30) — Other Operating Expenses: -5428000.00
CRI balance_sheet (quarterly, 2025-09-30) — Other Properties: 1400048000.00
CRI balance_sheet (quarterly, 2025-09-30) — Other Receivables: 13917000.00
CRI income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 305000.00
CRI balance_sheet (quarterly, 2025-09-30) — Payables: 258192000.00
CRI balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 264395000.00
CRI balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 31031000.00
CRI balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
CRI income_statement (quarterly, 2025-09-30) — Pretax Income: 14834000.00
CRI cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 0.00
CRI cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: 7741000.00
CRI balance_sheet (quarterly, 2025-09-30) — Receivables: 237866000.00
CRI balance_sheet (quarterly, 2025-09-30) — Receivables Adjustments Allowances: -15468000.00
CRI income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 416208000.00
CRI income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 13765000.00
CRI cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: 0.00
CRI balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 874355000.00
CRI income_statement (quarterly, 2025-09-30) — Selling General And Administration: 317963000.00
CRI balance_sheet (quarterly, 2025-09-30) — Share Issued: 36518637.00
CRI cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 3726000.00
CRI balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 864642000.00
CRI balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 366580000.00
CRI income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
CRI income_statement (quarterly, 2025-09-30) — Tax Provision: 3241000.00
CRI income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.22
CRI balance_sheet (quarterly, 2025-09-30) — Total Assets: 2469439000.00
CRI balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 1363380000.00
CRI balance_sheet (quarterly, 2025-09-30) — Total Debt: 1178425000.00
CRI balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 864642000.00
CRI income_statement (quarterly, 2025-09-30) — Total Expenses: 728743000.00
CRI balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 1604797000.00
CRI balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 1335658000.00
CRI balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 1103107000.00
CRI income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 29093000.00
CRI balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 17957000.00
CRI cash_flow (quarterly, 2025-09-30) — Unrealized Gain Loss On Investment Securities: -1003000.00
CRI balance_sheet (quarterly, 2025-09-30) — Working Capital: 632091000.00
CRI income_statement (annual, 2025-12-31) — +Operating Expense: 1170703000.00
CRI income_statement (quarterly, 2025-12-31) — +Operating Expense: 315465000.00
CRI income_statement (annual, 2025-12-31) — +Total Revenue: 2898426000.00
CRI income_statement (quarterly, 2025-12-31) — +Total Revenue: 925451000.00
CRI balance_sheet (annual, 2025-12-31) — Accounts Payable: 235700000.00
CRI balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 235700000.00
CRI balance_sheet (annual, 2025-12-31) — Accounts Receivable: 162850000.00
CRI balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 162850000.00
CRI balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -609059000.00
CRI balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -609059000.00
CRI balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 19584000.00
CRI balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 19584000.00
CRI balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -11716000.00
CRI balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -11716000.00
CRI cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 3719000.00
CRI cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 938000.00
CRI cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 3719000.00
CRI cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 938000.00
CRI cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 0.00
CRI cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: -21000.00
CRI income_statement (annual, 2025-12-31) — Basic Average Shares: 35404506.00
CRI income_statement (quarterly, 2025-12-31) — Basic Average Shares: 35448826.00
CRI income_statement (annual, 2025-12-31) — Basic EPS: 2.53
CRI income_statement (quarterly, 2025-12-31) — Basic EPS: 1.76
CRI cash_flow (annual, 2025-12-31) — Beginning Cash Position: 412926000.00
CRI cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 184190000.00
CRI cash_flow (annual, 2025-12-31) — Capital Expenditure: -53704000.00
CRI cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -11042000.00
CRI cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -53704000.00
CRI cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -11042000.00
CRI balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 644949000.00
CRI balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 644949000.00
CRI balance_sheet (annual, 2025-12-31) — Capital Stock: 364000.00
CRI balance_sheet (quarterly, 2025-12-31) — Capital Stock: 364000.00
CRI balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 487075000.00
CRI balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 487075000.00
CRI balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 508810000.00
CRI balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 508810000.00
CRI cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -56359000.00
CRI cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -9112000.00
CRI cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 2044000.00
CRI cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 54150000.00
CRI cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -53704000.00
CRI cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -11042000.00
CRI cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 122334000.00
CRI cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 258644000.00
CRI cash_flow (annual, 2025-12-31) — Change In Account Payable: -27246000.00
CRI cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -12300000.00
CRI cash_flow (annual, 2025-12-31) — Change In Inventory: -37101000.00
CRI cash_flow (quarterly, 2025-12-31) — Change In Inventory: 116520000.00
CRI cash_flow (annual, 2025-12-31) — Change In Payable: -27246000.00
CRI cash_flow (quarterly, 2025-12-31) — Change In Payable: -12300000.00
CRI cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -27246000.00
CRI cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -12300000.00
CRI cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -8098000.00
CRI cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 17411000.00
CRI cash_flow (annual, 2025-12-31) — Change In Receivables: 15169000.00
CRI cash_flow (quarterly, 2025-12-31) — Change In Receivables: 64062000.00
CRI cash_flow (annual, 2025-12-31) — Change In Working Capital: -57276000.00
CRI cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 185693000.00
CRI cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 15169000.00
CRI cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 64062000.00
CRI cash_flow (annual, 2025-12-31) — Changes In Cash: 70674000.00
CRI cash_flow (quarterly, 2025-12-31) — Changes In Cash: 301752000.00
CRI balance_sheet (annual, 2025-12-31) — Common Stock: 364000.00
CRI balance_sheet (quarterly, 2025-12-31) — Common Stock: 364000.00
CRI cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -56359000.00
CRI cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -9112000.00
CRI balance_sheet (annual, 2025-12-31) — Common Stock Equity: 925048000.00
CRI balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 925048000.00
CRI cash_flow (annual, 2025-12-31) — Common Stock Payments: 0.00
CRI cash_flow (quarterly, 2025-12-31) — Common Stock Payments: 0.00
CRI balance_sheet (annual, 2025-12-31) — Construction In Progress: 11244000.00
CRI balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 11244000.00
CRI income_statement (annual, 2025-12-31) — Cost Of Revenue: 1583790000.00
CRI income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 525293000.00
CRI balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 4236000.00
CRI balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 4236000.00
CRI balance_sheet (annual, 2025-12-31) — Current Assets: 1270773000.00
CRI balance_sheet (quarterly, 2025-12-31) — Current Assets: 1270773000.00
CRI balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 136488000.00
CRI balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 136488000.00
CRI balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 136488000.00
CRI balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 136488000.00
CRI balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 25994000.00
CRI balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 25994000.00
CRI balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 25994000.00
CRI balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 25994000.00
CRI balance_sheet (annual, 2025-12-31) — Current Liabilities: 505997000.00
CRI balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 505997000.00
CRI cash_flow (annual, 2025-12-31) — Deferred Income Tax: -162000.00
CRI cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -1041000.00
CRI cash_flow (annual, 2025-12-31) — Deferred Tax: -162000.00
CRI cash_flow (quarterly, 2025-12-31) — Deferred Tax: -1041000.00
CRI cash_flow (annual, 2025-12-31) — Depreciation: 51544000.00
CRI cash_flow (quarterly, 2025-12-31) — Depreciation: 13747000.00
CRI cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 55263000.00
CRI cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 14685000.00
CRI cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 55263000.00
CRI cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 14685000.00
CRI income_statement (annual, 2025-12-31) — Diluted Average Shares: 35404920.00
CRI income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 35449834.00
CRI income_statement (annual, 2025-12-31) — Diluted EPS: 2.53
CRI income_statement (quarterly, 2025-12-31) — Diluted EPS: 1.76
CRI income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 89490000.00
CRI income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 63030000.00
CRI income_statement (annual, 2025-12-31) — EBIT: 148061000.00
CRI income_statement (quarterly, 2025-12-31) — EBIT: 87326000.00
CRI income_statement (annual, 2025-12-31) — EBITDA: 203324000.00
CRI income_statement (quarterly, 2025-12-31) — EBITDA: 102011000.00
CRI cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 3475000.00
CRI cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 1133000.00
CRI cash_flow (annual, 2025-12-31) — End Cash Position: 487075000.00
CRI cash_flow (quarterly, 2025-12-31) — End Cash Position: 487075000.00
CRI cash_flow (annual, 2025-12-31) — Financing Cash Flow: 2044000.00
CRI cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 54150000.00
CRI balance_sheet (annual, 2025-12-31) — Finished Goods: 544624000.00
CRI balance_sheet (quarterly, 2025-12-31) — Finished Goods: 544624000.00
CRI cash_flow (annual, 2025-12-31) — Free Cash Flow: 68630000.00
CRI cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 247602000.00
CRI cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 189000.00
CRI balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -24361000.00
CRI balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -24361000.00
CRI balance_sheet (annual, 2025-12-31) — Goodwill: 208994000.00
CRI balance_sheet (quarterly, 2025-12-31) — Goodwill: 208994000.00
CRI balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 497781000.00
CRI balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 497781000.00
CRI balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 174566000.00
CRI balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 174566000.00
CRI balance_sheet (annual, 2025-12-31) — Gross PPE: 1387172000.00
CRI balance_sheet (quarterly, 2025-12-31) — Gross PPE: 1387172000.00
CRI income_statement (annual, 2025-12-31) — Gross Profit: 1314636000.00
CRI income_statement (quarterly, 2025-12-31) — Gross Profit: 400158000.00
CRI income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 0.00
CRI cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 37600000.00
CRI balance_sheet (annual, 2025-12-31) — Income Tax Payable: 635000.00
CRI balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 635000.00
CRI income_statement (annual, 2025-12-31) — Interest Expense: 34227000.00
CRI income_statement (quarterly, 2025-12-31) — Interest Expense: 11378000.00
CRI income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 34227000.00
CRI income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 11378000.00
CRI income_statement (annual, 2025-12-31) — Interest Income: 13474000.00
CRI income_statement (quarterly, 2025-12-31) — Interest Income: 3467000.00
CRI income_statement (annual, 2025-12-31) — Interest Income Non Operating: 13474000.00
CRI income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 3467000.00
CRI cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 35300000.00
CRI balance_sheet (annual, 2025-12-31) — Inventory: 544624000.00
CRI balance_sheet (quarterly, 2025-12-31) — Inventory: 544624000.00
CRI balance_sheet (annual, 2025-12-31) — Invested Capital: 1492221000.00
CRI balance_sheet (quarterly, 2025-12-31) — Invested Capital: 1492221000.00
CRI cash_flow (annual, 2025-12-31) — Investing Cash Flow: -53704000.00
CRI cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -11042000.00
CRI cash_flow (annual, 2025-12-31) — Issuance Of Debt: 575000000.00
CRI balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 508461000.00
CRI balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 508461000.00
CRI balance_sheet (annual, 2025-12-31) — Long Term Debt: 567173000.00
CRI balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 567173000.00
CRI balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1075634000.00
CRI balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1075634000.00
CRI cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 575000000.00
CRI cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -500000000.00
CRI balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 391480000.00
CRI balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 391480000.00
CRI cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 0.00
CRI cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
CRI balance_sheet (annual, 2025-12-31) — Net Debt: 80098000.00
CRI balance_sheet (quarterly, 2025-12-31) — Net Debt: 80098000.00
CRI cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -457000.00
CRI cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -64000.00
CRI income_statement (annual, 2025-12-31) — Net Income: 91796000.00
CRI income_statement (quarterly, 2025-12-31) — Net Income: 64218000.00
CRI income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 89490000.00
CRI income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 63030000.00
CRI income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 91796000.00
CRI income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 64218000.00
CRI income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 91796000.00
CRI income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 64218000.00
CRI income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 91796000.00
CRI income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 64218000.00
CRI cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 91796000.00
CRI cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 64218000.00
CRI income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 91796000.00
CRI income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 64218000.00
CRI income_statement (annual, 2025-12-31) — Net Interest Income: -20753000.00
CRI income_statement (quarterly, 2025-12-31) — Net Interest Income: -7911000.00
CRI cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 75000000.00
CRI cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 75000000.00
CRI income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -20753000.00
CRI income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -7911000.00
CRI cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -16597000.00
CRI cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -11738000.00
CRI balance_sheet (annual, 2025-12-31) — Net PPE: 778113000.00
CRI balance_sheet (quarterly, 2025-12-31) — Net PPE: 778113000.00
CRI cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: 0.00
CRI balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 427267000.00
CRI balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 427267000.00
CRI balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 39380000.00
CRI balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 39380000.00
CRI balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 39380000.00
CRI balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 39380000.00
CRI income_statement (annual, 2025-12-31) — Normalized EBITDA: 204979000.00
CRI income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 102011000.00
CRI income_statement (annual, 2025-12-31) — Normalized Income: 93129930.00
CRI income_statement (quarterly, 2025-12-31) — Normalized Income: 64218000.00
CRI cash_flow (annual, 2025-12-31) — Operating Cash Flow: 122334000.00
CRI cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 258644000.00
CRI cash_flow (annual, 2025-12-31) — Operating Gains Losses: 10164000.00
CRI cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 1780000.00
CRI income_statement (annual, 2025-12-31) — Operating Income: 143933000.00
CRI income_statement (quarterly, 2025-12-31) — Operating Income: 84693000.00
CRI income_statement (annual, 2025-12-31) — Operating Revenue: 2898426000.00
CRI income_statement (quarterly, 2025-12-31) — Operating Revenue: 925451000.00
CRI balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 36425877.00
CRI balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 36425877.00
CRI balance_sheet (annual, 2025-12-31) — Other Current Assets: 13571000.00
CRI balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 13571000.00
CRI balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 44728000.00
CRI balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 44728000.00
CRI balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -24361000.00
CRI balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -24361000.00
CRI income_statement (annual, 2025-12-31) — Other Income Expense: -9346000.00
CRI income_statement (quarterly, 2025-12-31) — Other Income Expense: -834000.00
CRI balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 288787000.00
CRI balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 288787000.00
CRI cash_flow (annual, 2025-12-31) — Other Non Cash Items: 1712000.00
CRI cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 459000.00
CRI balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 18803000.00
CRI balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 18803000.00
CRI balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 19411000.00
CRI balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 19411000.00
CRI income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -7691000.00
CRI income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 821000.00
CRI income_statement (annual, 2025-12-31) — Other Operating Expenses: -18102000.00
CRI income_statement (quarterly, 2025-12-31) — Other Operating Expenses: -4094000.00
CRI balance_sheet (annual, 2025-12-31) — Other Properties: 591806000.00
CRI balance_sheet (quarterly, 2025-12-31) — Other Properties: 591806000.00
CRI balance_sheet (annual, 2025-12-31) — Other Receivables: 15716000.00
CRI balance_sheet (quarterly, 2025-12-31) — Other Receivables: 15716000.00
CRI balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 21735000.00
CRI balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 21735000.00
CRI income_statement (annual, 2025-12-31) — Other Special Charges: 1655000.00
CRI income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 2306000.00
CRI income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 1188000.00
CRI balance_sheet (annual, 2025-12-31) — Payables: 246669000.00
CRI balance_sheet (quarterly, 2025-12-31) — Payables: 246669000.00
CRI balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 250905000.00
CRI balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 250905000.00
CRI cash_flow (annual, 2025-12-31) — Pension And Employee Benefit Expense: 8777000.00
CRI cash_flow (quarterly, 2025-12-31) — Pension And Employee Benefit Expense: 0.00
CRI balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 47882000.00
CRI balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 47882000.00
CRI balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
CRI balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
CRI balance_sheet (annual, 2025-12-31) — Prepaid Assets: 25202000.00
CRI balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 25202000.00
CRI income_statement (annual, 2025-12-31) — Pretax Income: 113834000.00
CRI income_statement (quarterly, 2025-12-31) — Pretax Income: 75948000.00
CRI cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
CRI cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
CRI balance_sheet (annual, 2025-12-31) — Properties: 392642000.00
CRI balance_sheet (quarterly, 2025-12-31) — Properties: 392642000.00
CRI cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 2818000.00
CRI cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: -7958000.00
CRI balance_sheet (annual, 2025-12-31) — Receivables: 178566000.00
CRI balance_sheet (quarterly, 2025-12-31) — Receivables: 178566000.00
CRI income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 1583790000.00
CRI income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 525293000.00
CRI income_statement (annual, 2025-12-31) — Reconciled Depreciation: 55263000.00
CRI income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 14685000.00
CRI cash_flow (annual, 2025-12-31) — Repayment Of Debt: -500000000.00
CRI cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: 0.00
CRI cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: 0.00
CRI balance_sheet (annual, 2025-12-31) — Retained Earnings: 929461000.00
CRI balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 929461000.00
CRI income_statement (annual, 2025-12-31) — Selling General And Administration: 1188805000.00
CRI income_statement (quarterly, 2025-12-31) — Selling General And Administration: 319559000.00
CRI balance_sheet (annual, 2025-12-31) — Share Issued: 36425877.00
CRI balance_sheet (quarterly, 2025-12-31) — Share Issued: 36425877.00
CRI cash_flow (annual, 2025-12-31) — Short Term Debt Issuance: 0.00
CRI cash_flow (annual, 2025-12-31) — Short Term Debt Payments: 0.00
CRI income_statement (annual, 2025-12-31) — Special Income Charges: -1655000.00
CRI cash_flow (annual, 2025-12-31) — Stock Based Compensation: 20248000.00
CRI cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 1581000.00
CRI balance_sheet (annual, 2025-12-31) — Stockholders Equity: 925048000.00
CRI balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 925048000.00
CRI balance_sheet (annual, 2025-12-31) — Tangible Book Value: 427267000.00
CRI balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 427267000.00
CRI income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -321070.00
CRI income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CRI income_statement (annual, 2025-12-31) — Tax Provision: 22038000.00
CRI income_statement (quarterly, 2025-12-31) — Tax Provision: 11730000.00
CRI income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.19
CRI income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.15
CRI balance_sheet (annual, 2025-12-31) — Total Assets: 2565470000.00
CRI balance_sheet (quarterly, 2025-12-31) — Total Assets: 2565470000.00
CRI balance_sheet (annual, 2025-12-31) — Total Capitalization: 1492221000.00
CRI balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 1492221000.00
CRI balance_sheet (annual, 2025-12-31) — Total Debt: 1212122000.00
CRI balance_sheet (quarterly, 2025-12-31) — Total Debt: 1212122000.00
CRI balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 925048000.00
CRI balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 925048000.00
CRI income_statement (annual, 2025-12-31) — Total Expenses: 2754493000.00
CRI income_statement (quarterly, 2025-12-31) — Total Expenses: 840758000.00
CRI balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 1640422000.00
CRI balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 1640422000.00
CRI balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 1294697000.00
CRI balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 1294697000.00
CRI balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 1134425000.00
CRI balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 1134425000.00
CRI income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 143933000.00
CRI income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 84693000.00
CRI balance_sheet (annual, 2025-12-31) — Total Tax Payable: 10969000.00
CRI balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 10969000.00
CRI income_statement (annual, 2025-12-31) — Total Unusual Items: -1655000.00
CRI income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -1655000.00
CRI cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -2229000.00
CRI cash_flow (quarterly, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -752000.00
CRI balance_sheet (annual, 2025-12-31) — Working Capital: 764776000.00
CRI balance_sheet (quarterly, 2025-12-31) — Working Capital: 764776000.00
CRI income_statement (quarterly, 2026-03-31) — +Operating Expense: 265430000.00
CRI income_statement (quarterly, 2026-03-31) — +Total Revenue: 681113000.00
CRI balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 188692000.00
CRI balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 192394000.00
CRI balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -617458000.00
CRI balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 20251000.00
CRI cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 941000.00
CRI cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 941000.00
CRI income_statement (quarterly, 2026-03-31) — Basic Average Shares: 35493430.00
CRI income_statement (quarterly, 2026-03-31) — Basic EPS: 0.39
CRI cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 487075000.00
CRI cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -6960000.00
CRI cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -6960000.00
CRI balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 628826000.00
CRI balance_sheet (quarterly, 2026-03-31) — Capital Stock: 369000.00
CRI balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 473435000.00
CRI balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 473435000.00
CRI cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -9220000.00
CRI cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -12232000.00
CRI cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -6960000.00
CRI cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 6417000.00
CRI cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -73541000.00
CRI cash_flow (quarterly, 2026-03-31) — Change In Inventory: 74994000.00
CRI cash_flow (quarterly, 2026-03-31) — Change In Payable: -73541000.00
CRI cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -73541000.00
CRI cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -14991000.00
CRI cash_flow (quarterly, 2026-03-31) — Change In Receivables: -16573000.00
CRI cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -30111000.00
CRI cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -16573000.00
CRI cash_flow (quarterly, 2026-03-31) — Changes In Cash: -12775000.00
CRI balance_sheet (quarterly, 2026-03-31) — Common Stock: 369000.00
CRI cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -9220000.00
CRI balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 928457000.00
CRI income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 387240000.00
CRI balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 16549000.00
CRI balance_sheet (quarterly, 2026-03-31) — Current Assets: 1211627000.00
CRI balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 133384000.00
CRI balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 133384000.00
CRI balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 25337000.00
CRI balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 25337000.00
CRI balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 433425000.00
CRI cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 3098000.00
CRI cash_flow (quarterly, 2026-03-31) — Deferred Tax: 3098000.00
CRI cash_flow (quarterly, 2026-03-31) — Depreciation: 12684000.00
CRI cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 13625000.00
CRI cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 13625000.00